Gerresheimer AG (GRRMF)
GRRMF Stock Price Chart
Explore Gerresheimer AG interactive price chart. Choose custom timeframes to analyze GRRMF price movements and trends.
GRRMF Company Profile
Discover essential business fundamentals and corporate details for Gerresheimer AG (GRRMF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
11 Sept 2009
Employees
13.63K
Website
https://www.gerresheimer.comCEO
Dietmar Siemssen
Description
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
GRRMF Financial Timeline
Browse a chronological timeline of Gerresheimer AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Apr 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 10 Oct 2025
Revenue estimate is $596.33M.
Earnings released on 10 Jul 2025
EPS came in at $0.56 falling short of the estimated $0.92 by -38.93%, while revenue for the quarter reached $681.89M , beating expectations by +13.79%.
Earnings released on 11 Apr 2025
EPS came in at -$0.54 falling short of the estimated $0.34 by -259.54%, while revenue for the quarter reached $540.93M , missing expectations by -0.31%.
Earnings released on 26 Feb 2025
EPS came in at $1.63 surpassing the estimated $1.57 by +3.82%, while revenue for the quarter reached $601.60M , missing expectations by -1.03%.
Dividend declared on 4 Feb 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 10 Jun 2025.
Earnings released on 30 Sept 2024
EPS came in at $1.16 falling short of the estimated $1.18 by -1.69%, while revenue for the quarter reached $550.60M , missing expectations by -1.59%.
Earnings released on 11 Jul 2024
EPS came in at $1.24 matching the estimated $1.24, while revenue for the quarter reached $544.95M , beating expectations by +6.23%.
Earnings released on 11 Apr 2024
EPS came in at $0.65 surpassing the estimated $0.64 by +1.56%, while revenue for the quarter reached $506.02M , beating expectations by +1.70%.
Earnings released on 22 Feb 2024
EPS came in at $1.51 surpassing the estimated $1.44 by +4.86%, while revenue for the quarter reached $594.71M , beating expectations by +1.11%.
Dividend declared on 9 Feb 2024
A dividend of $1.35 per share was announced, adjusted to $1.35. The dividend was paid on 10 Jun 2024.
Earnings released on 5 Oct 2023
EPS came in at $1.07 falling short of the estimated $1.11 by -3.60%, while revenue for the quarter reached $528.71M , missing expectations by -1.14%.
Earnings released on 6 Jul 2023
EPS came in at $1.30 surpassing the estimated $1.28 by +1.56%, while revenue for the quarter reached $535.63M , beating expectations by +1.58%.
Earnings released on 28 Feb 2023
EPS came in at $0.41 falling short of the estimated $0.70 by -41.96%, while revenue for the quarter reached $486.74M , beating expectations by +1.37%.
Dividend declared on 27 Feb 2023
A dividend of $1.35 per share was announced, adjusted to $1.25. The dividend was paid on 12 Jun 2023.
Earnings released on 23 Feb 2023
EPS came in at $1.49 surpassing the estimated $1.47 by +1.36%, while revenue for the quarter reached $553.65M , beating expectations by +1.70%.
Earnings released on 12 Oct 2022
EPS came in at $1.15 falling short of the estimated $1.25 by -8.00%, while revenue for the quarter reached $471.71M , beating expectations by +1.54%.
Earnings released on 13 Jul 2022
EPS came in at $1.34 surpassing the estimated $1.20 by +11.67%, while revenue for the quarter reached $476.14M , beating expectations by +1.63%.
Earnings released on 7 Apr 2022
EPS came in at $0.63 matching the estimated $0.63, while revenue for the quarter reached $407.94M , beating expectations by +3.07%.
Dividend declared on 22 Feb 2022
A dividend of $1.33 per share was announced, adjusted to $1.25. The dividend was paid on 13 Jun 2022.
Earnings released on 17 Feb 2022
EPS came in at $1.31 surpassing the estimated $1.23 by +6.50%, while revenue for the quarter reached $1.69B , beating expectations by +242.04%.
Earnings released on 12 Oct 2021
EPS came in at $0.97 falling short of the estimated $1.00 by -3.00%, while revenue for the quarter reached $452.99M , beating expectations by +20.48%.
Earnings released on 13 Jul 2021
EPS came in at $1.28 surpassing the estimated $1.16 by +10.34%, while revenue for the quarter reached $458.91M .
Dividend declared on 27 Apr 2021
A dividend of $1.52 per share was announced, adjusted to $1.25. The dividend was paid on 14 Jun 2021.
Earnings released on 8 Apr 2021
EPS came in at $0.57 surpassing the estimated $0.44 by +29.55%, while revenue for the quarter reached $367.24M .
Earnings released on 18 Feb 2021
EPS came in at $1.31 falling short of the estimated $1.35 by -2.96%, while revenue for the quarter reached $488.03M .
Earnings released on 13 Oct 2020
EPS came in at $0.97 surpassing the estimated $0.94 by +3.19%, while revenue for the quarter reached $413.79M .
GRRMF Stock Performance
Access detailed GRRMF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.